Stockfacts
Explore
Use Cases
Docs
Pricing
English
Log in
Sign up free
Overview
Financials
Trends
Transcripts
Options
Shorts
Institutions
Insiders
Corporate Actions
SEC Filings
TARS
Tarsus Pharmaceuticals, Inc.
CIK 0001819790 · Nasdaq
Nasdaq
Health Care
Biological Products, (No Diagnostic Substances)
$72.70
↑ 1.21 (1.69%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read:
Neutral
Overall score · based on 4/4 lenses
Fundamentals
Ownership
Technicals
Options
Bullish: Ownership; Risks: Options
Key stats
Market Cap
$3.19B
P/E Ratio
-68.64
EPS
-1.59
Dividend Yield
Not covered
52W Position
66%
Beta
0.58
Valuation multiples
Fwd P/E
106.38
PEG
Not covered
P/B
9.20
P/S
5.26
EV/Revenue
5.04
ROE
-13.4%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).
Price · 1Y
251 trading days
End-of-day close, not real-time intraday
52-Week Range
Position 66%
$48.20
$85.25
Latest Financials
2025-12-31 FY
Revenue
$451.36M
Net Income
-$66.42M
Total Assets
$562.16M
Free Cash Flow
-$22.31M
Recent news